Company news

Personalis, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference

February 17, 2025

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

February 12, 2025

Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 27, 2025

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue

January 6, 2025

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

December 18, 2024

Personalis and Tempus Expand Collaboration to Biopharma

December 15, 2024

Personalis to Participate at Upcoming Investor Conferences

November 19, 2024

Personalis Reports Third Quarter 2024 Financial Results

November 5, 2024

Personalis to Present at the Stifel 2024 Healthcare Conference

November 4, 2024

Personalis to Announce Third Quarter 2024 Financial Results

October 22, 2024

ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test

September 15, 2024

Personalis and Tempus Announce Expanded Collaboration

August 15, 2024

Personalis Reports Second Quarter 2024 Financial Results

August 6, 2024

Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

July 30, 2024

Personalis to Announce Second Quarter 2024 Financial Results

July 23, 2024

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

July 10, 2024

Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference

June 17, 2024

Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call

June 12, 2024

ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring

June 3, 2024

Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus

May 30, 2024

Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024

May 21, 2024

Personalis Reports First Quarter 2024 Financial Results

May 7, 2024

Personalis to Announce First Quarter 2024 Financial Results

April 23, 2024

Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference

March 27, 2024

Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting

March 27, 2024

Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring

March 25, 2024

Personalis Reports Fourth Quarter and Full Year 2023 Financial Results

February 27, 2024

Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results

February 13, 2024

Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology

January 29, 2024

Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

January 15, 2024

Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance

January 4, 2024

Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives

December 3, 2023

Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing

November 27, 2023

Personalis Reports Third Quarter 2023 Financial Results

November 6, 2023

Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer

October 25, 2023

Personalis to Announce Third Quarter 2023 Financial Results

October 23, 2023

Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology

October 20, 2023

Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023

October 18, 2023

Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance

October 17, 2023

Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference

August 28, 2023

Personalis Reports Second Quarter 2023 Financial Results

August 7, 2023

Personalis to Announce Second Quarter 2023 Financial Results

July 24, 2023

Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics

June 25, 2023

Dr. Kenneth J. Widder Joins Personalis Board of Directors

June 12, 2023

Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023

May 29, 2023

Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

May 15, 2023

Personalis Reports First Quarter 2023 Financial Results

May 2, 2023

Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer

May 1, 2023

Personalis to Announce First Quarter 2023 Financial Results

April 18, 2023

Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference

April 4, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks